Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jul;34(3):351-364.
doi: 10.1016/j.semradonc.2024.04.008.

Navigating the Critical Translational Questions for Implementing FLASH in the Clinic

Billy W Loo Jr  1 , Ioannis I Verginadis  2 , Brita Singers Sørensen  3 , Anthony E Mascia  4 , John P Perentesis  4 , Albert C Koong  5 , Emil Schüler  6 , Erinn B Rankin  7 , Peter G Maxim  8 , Charles L Limoli  8 , Marie-Catherine Vozenin  9
Affiliations
Review

Navigating the Critical Translational Questions for Implementing FLASH in the Clinic

Billy W Loo Jr et al. Semin Radiat Oncol. 2024 Jul.

Abstract

The "FLASH effect" is an increased therapeutic index, that is, reduced normal tissue toxicity for a given degree of anti-cancer efficacy, produced by ultra-rapid irradiation delivered on time scales orders of magnitude shorter than currently conventional in the clinic for the same doses. This phenomenon has been observed in numerous preclinical in vivo tumor and normal tissue models. While the underlying biological mechanism(s) remain to be elucidated, a path to clinical implementation of FLASH can be paved by addressing several critical translational questions. Technological questions pertinent to each beam type (eg, electron, proton, photon) also dictate the logical progression of experimentation required to move forward in safe and decisive clinical trials. Here we review the available preclinical data pertaining to these questions and how they may inform strategies for FLASH cancer therapy clinical trials.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Summary of answers to critical translational questions based on current preclinical data.
See this image and copyright information in PMC

References

    1. Alaghband Yasaman, Cheeks Samantha N., Allen Barrett D., Pierre Montay-Gruel Ngoc-Lien Doan, Petit Benoit, Jorge Patrik Goncalves, et al. 2020. “Neuroprotection of Radiosensitive Juvenile Mice by Ultra-High Dose Rate FLASH Irradiation.” Cancers 12 (6): 1671. 10.3390/cancers12061671. - DOI - PMC - PubMed
    1. Alaghband Yasaman, Barrett D Allen, Eniko A Kramar, Richard Zhang, Olivia G.G Drayson, Ning Ru, Benoit Petit, et al. 2023. “Uncovering the Protective Neurological Mechanisms of Hypofractionated FLASH Radiotherapy.” Cancer Research Communications 3 (4): 725–37. 10.1158/2767-9764.crc-23-0117. - DOI - PMC - PubMed
    1. Allen Barrett, Yasaman Alaghband, Eniko A Kramár, Ning Ru, Benoit Petit, Veljko Grilj, Michael S Petronek, et al. 2022. “Elucidating the Neurological Mechanism of the FLASH Effect in Juvenile Mice Exposed to Hypofractionated Radiotherapy.” Neuro-Oncology. 10.1093/neuonc/noac248. - DOI - PMC - PubMed
    1. Almeida A, Togno, Ballesteros-Zebadua P, Franco-Perez J, Geyer R, Schaefer R, Petit B, et al. 2024. “Dosimetric and Biologic Intercomparison between Electron and Proton FLASH Beams.” Radiotherapy and Oncology 190: 109953. 10.1016/j.radonc.2023.109953. - DOI - PubMed
    1. American Society for Radiation Oncology (ASTRO). 2023. Radiation Therapy For Cancer. https://rtanswers.org/RTAnswers/media/RTAnswers/patient%20materials/PDFs....